JNJack Kit-Chung Ng

Jack Kit-Chung Ng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jack Kit-Chung Ng has a total of 153 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Recommendations for the management of frailty in chronic kidney disease: a consensus report

    by Philip Kam-Tao Li, Gordon Chun-Kau Chan, Mara McAdams-DeMarco, Stephanie Thompson, Marjolijn van Buren, Andrew C. Nixon, Jack Kit-Chung Ng, Ruth E. Hubbard, Sarbjit Vanita Jassal, Chia-Ter Chao, et al.

    Frailty is highly prevalent in patients with chronic kidney disease (CKD) and is associated with increased mortality, hospitalization and disability and with poorer quality of life. Despite its prognostic importance, substantial knowledge gaps remain with regard to the optimal tools for assessing frailty in CKD settings, the extent to which frailty can be reversed through targeted interventions, and how frailty should inform decision-making between conservative kidney management and kidney replacement therapy (KRT). This consensus report provides 63 consensus statements across four domains covering the assessment of frailty, interventions aimed at targeting the modifiable contributors to frailty in patients with CKD, considerations related to conservative kidney management and KRT, and the management of stage 5 CKD in the presence of frailty. Key recommendations include the need for routine frailty screening using multi-dimensional tools; the implementation of interventions to target physical activity with a focus on resistance training, adequate dietary protein intake, medication optimization and comprehensive geriatric assessment; a frailty-informed, person-centred framework for shared decision-making that emphasizes transparent communication, goal elicitation and cultural safety; and flexible KRT delivery — including less intensive dialysis schedules, assisted home dialysis and transplant eligibility assessment — guided by serial frailty measurement. The report concludes with priority research questions and a patient partner’s reflections on the co-production of consensus statements.


    • 18 July 2026
      • p. 113442

    Variability in magnitude and direction of discordance between continuous glucose monitoring (CGM) metrics and traditional biomarkers in patients with diabetes and end-stage kidney disease (ESKD): A case series.

    by Yunyao Lin, James Ling, Risa Ozaki, Sze Kit Yuen, Cheuk Chun Szeto, Jack Kc Ng, Elaine Chow

    In four patients with diabetes and end-stage kidney disease, glycated hemoglobin A1c (HbA1c) showed marked, time-varying discordance with continuous glucose monitoring (CGM)-derived glucose management indicator, ranging from - 2.1% to + 6.2%. Anemia, erythropoiesis-stimulating therapy, iron disturbances, hemoglobinopathy, transfusion and glycemic variability contributed, supporting CGM metrics for safer assessment and treatment adjustment.

  • Open Access

    Zinc alpha-2-glycoprotein in peritoneal dialysis effluent correlates with peritoneal transport characteristics, peritonitis rate, and outcome

    by Gordon Chun-Kau Chan, Win Hlaing Than, Bonnie Ching-Ha Kwan, Ka-Bik Lai, Ronald Cheong-Kin Chan, Jeremy Yuen-Chun Teoh, Jack Kit-Chung Ng, Kai-Ming Chow, Phyllis Mei-Shan Cheng, Man-Ching Law, et al.

    Background: There were limited data on zinc alpha-2-glycoprotein (ZAG) levels and their association with peritoneal characteristics and clinical outcomes in patients undergoing peritoneal dialysis (PD). We aimed to quantify and explore the correlation between ZAG levels in PD effluent (PDE), adipose, and serum samples from PD patients, and to evaluate their association with peritoneal characteristics and outcome.Methods: Incident adult PD patients were enrolled in this prospective cohort study. We measured ZAG levels in PDE, serum, and pre-peritoneal fat tissue samples. Peritoneal characteristics were determined by the standard peritoneal equilibrium test. Primary and secondary outcomes were the 2-year peritonitis rate and peritonitis-related clinical outcomes, respectively.Results: We analyzed 126 patients. At baseline, PDE, adipose, and circulating ZAG levels were 1.0 ± 1.2 μg/mL, 15.3 ± 140.5-fold, and 74.4 ± 21.5 μg/mL, respectively. PDE ZAG correlated with adipose ZAG (r = 0.21, p = 0.02), but not with serum ZAG (p = 0.30). PDE ZAG independently predicted small solute peritoneal transport, i.e., dialysate-to-plasma ratio of creatinine at 4 hours (p = 0.01) and mass transfer area coefficient of creatinine (p = 0.04), but not peritoneal protein clearance (p = 0.90). After 222.7 patient-years of follow-up, 40 patients (31.7%) developed 66 peritonitis episodes, and nine patients died. PDE ZAG predicted peritonitis (unstandardized B = 0.446, p < 0.001) and peritonitis-free survival (hazard ratio, 1.36; p = 0.02) after adjustment for confounders.Conclusion: PDE ZAG level significantly correlated with peritoneal transport characteristics and was associated with peritonitis and peritonitis-free survival in PD patients.

  • Open Access

    Assessment of Muscle Mass and Diagnosis of Sarcopenia in Peritoneal Dialysis Patients

    by Lixing Xu, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto

    Sarcopenia is characterized by the progressive loss of muscle mass and function, and it represents a significant and prevalent condition in patients undergoing peritoneal dialysis (PD). However, limited research has been conducted to document techniques for the early detection of sarcopenia in adult PD patients. This review addresses the pathophysiology, prognostic implications, and various assessment techniques for sarcopenia, including creatinine kinetics, anthropometry, imaging techniques (computed tomography, magnetic resonance imaging, and ultrasound sonography), bioimpedance spectrometry, and the modified creatinine index. Each of these techniques presents unique strengths and limitations, necessitating careful consideration of the most appropriate assessment method based on specific clinical conditions. By synthesizing current knowledge, this review aims to evaluate the strengths and limitations of available muscle-assessment techniques and assist in the development of improved diagnostic strategies for sarcopenic adult PD patients.

  • Open Access

    Assessment of Muscle Mass and Diagnosis of Sarcopenia in Peritoneal Dialysis Patients

    by Lixing Xu, Jack Kc Ng, Winston Ws Fung, Gordon Ck Chan, Kai-Ming Chow, Cheuk Chun Szeto

    Sarcopenia is characterized by the progressive loss of muscle mass and function, and it represents a significant and prevalent condition in patients undergoing peritoneal dialysis (PD). However, limited research has been conducted to document techniques for the early detection of sarcopenia in PD patients. This review addresses the pathophysiology, prognostic implications, and various assessment techniques for sarcopenia, including creatinine kinetics, anthropometry, imaging techniques (computer tomography, magnetic resonance imaging, and ultrasound sonography), bioimpedance spectrometry, and the modified creatinine index. Each of these techniques presents unique strengths and limitations, necessitating careful consideration of the most appropriate assessment method based on specific clinical conditions. By synthesizing current knowledge, this review aims to evaluate the strengths and limitations of available muscle-assessment techniques and assist in the development of improved diagnostic strategies for sarcopenic PD patients.

  • Open Access

    The Impact of Change in Body Roundness Index on the Clinical Outcome of New Peritoneal Dialysis Patients

    by Lixing Xu, Jack Kit-Chung Ng, Gordon Chun-Kau Chan, Winston Wing-Shing Fung, Kai Ming Chow, Cheuk-Chun Szeto

    Introduction: Weight gain and central obesity are common in peritoneal dialysis (PD) patients. In the general population, body roundness index (BRI) has been found to be a convenient anthropometric measurement for the assessment of central obesity and visceral adiposity. However, the role of BRI in PD patients has not been explored. Methods: We recruited 145 new PD patients. BRI, body composition by bioimpedance spectroscopy, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) were measured at baseline and then after 1 year of PD. Patients were stratified into four groups based on their changes in BRI after 1 year of PD, using the traditional BRI cutoff of 5. Outcome measures include patient survival and hospitalization rate. Results: The change in BRI after 1 year of PD had a modest but significant correlation with the change in HOMA-IR (r = 0.497, p = 0.041). For the group with baseline BRI <5, patients who had their BRI raised to ≥5 (low-high group, n = 20) had significantly lower patient and technique survival rates than those whose BRI remained <5 (low-low group, n = 55), and the result remained significant after adjusting for clinical confounders by multi-variable Cox regression (adjusted hazard ratio 2.885, 95% CI: 1.278–6.509, p = 0.011). The low-high group also had significantly higher hospitalization rates (2.51 [1.63–3.93] vs. 0.98 [0.26–1.91] per year, p = 0.0008) and longer hospitalization stay (17.3 [12.2–35.5] vs. 5.0 [1.0–13.3] days per year, p = 0.015) than the low-low group. Conclusion: An increase in BRI after 1 year of PD was associated with worsening of insulin resistance, worse patient survival, and more hospitalization.

  • Open Access

    Circulating Muscle Markers for Sarcopenia in Peritoneal Dialysis

    by Lixing Xu, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto

    Sarcopenia, characterized by the progressive decline in muscle mass and function, is an important complication among patients undergoing peritoneal dialysis (PD). Despite its prevalence, there is a notable lack of comprehensive research focused on early diagnosis or treatment target for sarcopenia in PD patients. This review explores the pathophysiology of sarcopenia and examines the potential role of various biomarkers related to muscle mass and function. These markers include myokines (cytokines produced by skeletal muscle) such as myostatin, follistatin, activin A, growth differentiation factor 15 (GDF‐15), and irisin, as well as adiponectin, leptin, insulin‐like growth factor‐1 (IGF‐1), vitamin D, myoglobin, and cortisol. These markers hold promise for early diagnosis and as therapeutic targets for managing sarcopenia. By reviewing the current literature in this area, we aim to identify directions for further research on diagnostic strategies and therapeutic options for sarcopenic PD patients.


  • Open Access

    Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis

    by Chuanlei Li, Jack Kit-Chung Ng, Gordon Chun-Kau Chan, Winston Wing-Shing Fung, Ka-Bik Lai, Peter Yam-Kau Poon, Cathy Choi-Wan Luk, Kai-Ming Chow, Cheuk-Chun Szeto

    Limited data exist on the association between gut permeability, circulating bacterial fragment and volume overload in peritoneal dialysis (PD) patients. We measured circulating bacterial fragments, N-terminal pro B-type natriuretic peptide (NT-proBNP), calprotectin and zonulin levels, and evaluate their association with the clinical outcomes in PD patients. This was a single-center prospective study on 108 consecutive incident PD patients. Plasma endotoxin and bacterial DNA, and serum NT-proBNP, calprotectin and zonulin levels were measured. Primary outcomes were technique and patient survival, secondary outcomes were hospitalization data. There was no significant correlation between plasma endotoxin and bacterial DNA, and serum NT-proBNP, calprotectin and zonulin levels. The Homeostatic Model Assessment for Insulin Resistance (HOMA)-2β index, which represents insulin resistance, positively correlated with plasma bacterial DNA (r = 0.421, P < .001) and calprotectin levels (r = 0.362, P = .003), while serum NT-proBNP level correlated with the severity of volume overload and residual renal function. Serum NT-proBNP level was associated with technique survival even after adjusting for confounding factors [adjusted hazard ratio (aHR) 1.030, 95% confidence interval 1.009–1.051]. NT-proBNP level was also associated with patient survival by univariate analysis, but the association became insignificant after adjusting for confounding factors (aHR 1.010, P = .073). Similarly, NT-proBNP correlated with the number of hospitalizations and duration of hospitalization by univariate analysis, but the association became insignificant after adjusting for confounding factors. There was no correlation between markers of gut permeability, circulating bacterial fragments and measures of congestion in PD patients. Bacterial fragments levels and gut permeability are both associated with insulin resistance. Serum NT-proBNP level is associated with the severity of volume overload and technique survival. Further studies are required to delineate the mechanism of high circulating bacterial fragment levels in PD patients.


  • Open Access

    Nutritional Assessments by Bioimpedance Technique in Dialysis Patients

    by Jack Kit-Chung Ng, Sam Lik-Fung Lau, Gordon Chun-Kau Chan, Na Tian, Philip Kam-Tao Li

    Bioelectrical impedance analysis (BIA) has been extensively applied in nutritional assessments on the general population, and it is recommended in establishing the diagnosis of malnutrition and sarcopenia. The bioimpedance technique has become a promising modality through which to measure the whole-body composition in dialysis patients, where the presence of subclinical volume overload and sarcopenic obesity may be overlooked by assessing body weight alone. In the past two decades, bioimpedance devices have evolved from applying a single frequency to a range of frequencies (bioimpedance spectroscopy, BIS), in which the latter is incorporated with a three-compartment model that allows for the simultaneous measurement of the volume of overhydration, adipose tissue mass (ATM), and lean tissue mass (LTM). However, clinicians should be aware of common potential limitations, such as the adoption of population-specific prediction equations in some BIA devices. Inherent prediction error does exist in the bioimpedance technique, but the extent to which this error becomes clinically significant remains to be determined. Importantly, reduction in LTM has been associated with increased risk of frailty, hospitalization, and mortality in dialysis patients, whereas the prognostic value of ATM remains debatable. Further studies are needed to determine whether modifications of bioimpedance-derived body composition parameters through nutrition intervention can result in clinical benefits.